Volume 18, Number 3—March 2012
Research
Seroprevalence of Antibodies against Taenia solium Cysticerci among Refugees Resettled in United States
Table 1
Country of origin | Male refugees |
Female refugees |
Odds ratio* (95% CI) | p value† | |||
---|---|---|---|---|---|---|---|
No. positive/total no. | % (95% CI) | No. positive/total no. | % (95% CI) | ||||
Burma (Myanmar) | 78/273 | 28.6 (23.2–34.0) | 38/226 | 16.8 (11.9–21.7) | 2.0 (1.3–3.1) | <0.01 | |
Laos | 41/240 | 17.1 (12.3–21.9) | 51/262 | 19.5 (14.7–24.3) | 0.9 (0.5–1.3) | 0.49 | |
Burundi | 57/234 | 24.4 (18.8–29.9) | 72/266 | 27.1 (21.7–32.4) | 0.9 (0.6–1.3) | 0.49 | |
Bhutan | 56/237 | 23.6 (18.2–29.1) | 58/263 | 22.1 (17.0–27.1) | 1.1 (0.7–1.7) | 0.68 | |
Total | 232/984 | 23.6 (20.9–26.2) | 219/1,017 | 21.5 (19.0–24.1) | 1.1 (0.9–1.4) | 0.27 |
*Odds of positive result for enzyme-linked immunoelectrotransfer blot for lentil-lectin purified glycoprotein (EITB LLGP) testing of samples from male refugees compared with samples from female refugees.
†Pearson χ2.
Page created: February 16, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.